Waseem Shaukat

Mr. Waseem Shaukat

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 December 2022 in Preventive Veterinary Medicine
Verified
Journal Article
Closed access
ASAyesha Saman
Ayesha Saman
MCMamoona Chaudhry
Mamoona Chaudhry
MIMuhammad Ijaz
Muhammad Ijaz
WSWaseem Shaukat
Waseem Shaukat
MZMuhammad Usman Zaheer
Muhammad Usman Zaheer
Abdul REHMANAbdul REHMAN
Abdul REHMAN

1 October 2024 in Journal of Dairy Science
Verified
Journal Article
Open access
WSWaseem Shaukat
Waseem Shaukat
EJEllen de Jong
Ellen de Jong
KMKayley D. McCubbin
Kayley D. McCubbin
MBMarit M. Biesheuvel
Marit M. Biesheuvel
FMFrank J.U.M. van der Meer
Frank J.U.M. van der Meer
HBHerman Wildrik Barkema
Herman Wildrik Barkema

26 November 2022 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
BMBayan Missaghi
Bayan Missaghi
MMMuhammad Wasif Malik
Muhammad Wasif Malik
WSWaseem Shaukat
Waseem Shaukat
MRMuazam Abbas Ranjha
Muazam Abbas Ranjha
AIAamer Ikram
Aamer Ikram
HBHerman Wildrik Barkema
Herman Wildrik Barkema
Background: Persons in Pakistan have suffered from various infectious diseases over the years, each impacted by various factors including climate change, seasonality, geopolitics, and resource availability. The COVID-19 pandemic is another complicating factor, with changes in the reported incidence of endemic infectious diseases and related syndromes under surveillance. Methods: We assessed the monthly incidence of eight important infectious diseases/syndromes: acute upper respiratory infection (AURI), viral hepatitis, malaria, pneumonia, diarrhea, typhoid fever, measles, and neonatal tetanus (NNT), before and after the onset of the COVID-19 pandemic. Administrative health data of monthly reported cases of these diseases/syndromes from all five provinces/regions of Pakistan for a 3-year interval (March 2018–February 2021) were analyzed using an interrupted time series approach. Reported monthly incidence for each infectious disease agent or syndrome and COVID-19 were subjected to time series visualization. Spearman’s rank correlation coefficient between each infectious disease/syndrome and COVID-19 was calculated and median case numbers of each disease before and after the onset of the COVID-19 pandemic were compared using a Wilcoxon signed-rank test. Subsequently, a generalized linear negative binomial regression model was developed to determine the association between reported cases of each disease and COVID-19. Results: In late February 2020, concurrent with the start of COVID-19, in all provinces, there were decreases in the reported incidence of the following diseases: AURI, pneumonia, hepatitis, diarrhea, typhoid, and measles. In contrast, the incidence of COVID was negatively associated with the reported incidence of NNT only in Punjab and Sindh, but not in Khyber Pakhtunkhwa (KPK), Balochistan, or Azad Jammu & Kashmir (AJK) & Gilgit Baltistan (GB). Similarly, COVID-19 was associated with a lowered incidence of malaria in Punjab, Sindh, and AJK & GB, but not in KPK and Balochistan. Conclusions: COVID-19 was associated with a decreased reported incidence of most infectious diseases/syndromes studied in most provinces of Pakistan. However, exceptions included NNT in KPK, Balochistan and AJK & GB, and malaria in KPK and Balochistan. This general trend was attributed to a combination of resource diversion, misdiagnosis, misclassification, misinformation, and seasonal patterns of each disease.

20 May 2025 in Pathogens
Verified
Journal Article
Open access
PDF file
Abdul GhafarAbdul Ghafar
Abdul Ghafar
WSWaseem Shaukat
Waseem Shaukat
MWMuhammad Waqas
Muhammad Waqas
CGCharles Gauci
Charles Gauci
RGRobin Gasser
Robin Gasser
Abdul JabbarAbdul Jabbar
Abdul Jabbar
Bovine anaplasmosis, caused by Anaplasma marginale, is a major tick-borne disease in tropical and subtropical regions of the world, leading to significant production losses. Prolonged convalescence periods are common and surviving animals often become subclinical carriers. This study aimed to detect and characterise A. marginale in bovines in smallholder dairy farms across diverse climatic zones of Pakistan using molecular methods. In total, 321 blood DNA samples from apparently healthy cattle (n = 174) and buffaloes (n = 147) from six districts in Pakistan were tested for A. marginale using a nested PCR assay, targeting part of the major surface protein B gene (msp1β) as a genetic marker, followed by agarose gel electrophoresis and selective sequencing of amplicons from test-positive samples. Of the 321 DNA samples tested, 135 (42.1%) were test-positive for A. marginale. Prevalence was significantly higher in cattle (64.4%; 112/174) than in buffaloes (15.6%; 23/147), and female bovines (43.5%; 108/248) were more frequently infected than males (37%; 27/73). Phylogenetic analysis of the msp1β sequence data (n = 42) revealed that A. marginale from Pakistan clustered with those from Brazil, Thailand, South Africa, and the USA. This study represents the first comprehensive investigation of A. marginale from bovines from diverse agroecological zones of Pakistan and will further stimulate population genetic studies of A. marginale and investigations into the economic impact of subclinical infections in bovines in smallholder farming systems.

1 January 2026 in Journal of Dairy Science
Verified
Journal Article
Open access
MMM.P. Morin
M.P. Morin
JSJuan Carlos Arango Sabogal
Juan Carlos Arango Sabogal
JRJean-Philippe Roy
Jean-Philippe Roy
GFG. Fecteau
G. Fecteau
FFF. Farison
F. Farison
SDSimon Dufour
Simon Dufour
Vaccination is commonly used on Canadian dairy farms as a routine herd management practice to prevent infection with bovine viral diarrhea virus (BVDV) and to control its effects. This study aimed to determine the humoral immune response to vaccination with modified live BVDV vaccines administered on commercial dairy farms. A multisite observational cross-sectional study was conducted on 310 dairy herds across 3 Canadian provinces (Alberta, Ontario, and Québec), including 2,866 cattle aged 4 to 24 mo, either vaccinated or unvaccinated against BVDV. Vaccines used and vaccination protocols were farm specific. On a farm visit, up to 10 animals aged between 4 and 24 mo were selected, and their vaccination status against bovine viral diarrhea (BVD) was recorded (date of most recent BVD vaccination and brand of vaccine). Antibody ELISA were performed to assess the association between animal age at sampling and the time since vaccination with (1) the humoral immune response, measured by the sample-to-positive (S/P) ratio of a BVDV ELISA antibody test using negative binomial regression; and (2) the probability of testing positive on the same ELISA test (i.e., S/P ratio >0.199) using logistic regression. Time since vaccination and age at sampling were associated with the measured humoral immune response. The probability of a positive ELISA result increased significantly with time since vaccination, reaching 90% positivity in calves aged 4 to 10 mo and nearly 99% positivity in older young stock (>10 mo) by 28 d after vaccination. Animals aged 4 to 10 mo required a longer period of time before demonstrating a measurable humoral immune response. In conclusion, the results of this study demonstrate that vaccines administered under real farm conditions will lead to a measurable humoral response in the majority of calves and young stock. This suggests that modified live vaccines against BVDV are effective in inducing humoral immunity in young stock on commercial dairy farms.

1 June 2026 in Journal of Dairy Science
Verified
Journal Article
Open access
WSWaseem Shaukat
Waseem Shaukat
DNDiego Nobrega
Diego Nobrega
KKKristen N. Kalbfleisch
Kristen N. Kalbfleisch
JKJohn P. Kastelic
John P. Kastelic
DKDavid Kelton
David Kelton
HBHerman Wildrik Barkema
Herman Wildrik Barkema
Mastitis continues to be among the top 3 challenges for dairy production globally, resulting in substantial economic losses. Current pathogen-specific prevalence estimates are crucial for effective surveillance and disease control. The objective of this study was to estimate the true prevalence of herds positive for major contagious mastitis pathogens in Alberta, Canada, and to describe bulk tank SCC (BTSCC) patterns and dynamics. Using a serial cross-sectional study design, bulk tank milk (BTM) samples were collected from all active dairy producers in Alberta in December 2021 (n = 484), April 2022 (n = 486), and October 2022 (n = 484) and tested for Staphylococcus aureus, Streptococcus agalactiae, and Mycoplasma bovis using a commercial multiplex quantitative-PCR kit. The BTSCC data for 2021 and 2022 were obtained for each herd for each milk pick-up and production-weighted geometric mean BTSCC (PWgBTSCC) was calculated. True prevalence was estimated using Bayesian latent class models. Mixed-effect modified Poisson and linear regression models were used to assess associations among pathogen positivity, herd characteristics, and PWgBTSCC. True prevalence of Staph. aureus-positive herds were 17.8%, 11.0%, and 13.8% in December, April, and October, respectively, whereas for Strep. agalactiae, true prevalence was consistent at 0.6%. For M. bovis, true prevalence was 2.0%, 4.7%, and 3.6% in December, July, and October, respectively. The prevalence of Staph. aureus-positive herds was higher (prevalence ratio [PR] = 1.31) among medium-sized herds (3,600-7,200 L/d milk delivered) compared with smaller herds (200,000 cells/mL) annual PWgBTSCC were more frequently Staph. aureus-positive (PR = 1.58 and 2.40, respectively) compared with <100,000 cells/mL herds. Annual PWgBTSCC was elevated for herds testing positive for any major contagious mastitis pathogen at least once compared with consistently negative herds. Herds in the south region had an 11% lower annual PWgBTSCC compared with north-region herds. These findings provided updated prevalence estimates of major contagious mastitis pathogens and critical insights into BTSCC patterns across herd types and regions, supporting targeted within-herd diagnostic follow-up and evidence-based mastitis control strategies.